Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Seattle Genetics, Inc. (SGEN)
(
)
Quote & Articles
Transcripts
Instablogs
Comments on articles
Cramer
Authors on SGEN
Newest on SGEN
Value Expectations
(2)
Market Folly
(1)
Dan Rosenblum
(1)
Don Dion
(1)
Mike Havrilla
(1)
Most frequent on SGEN
Ohad Hammer
(
15
)
Centient Biotech Investor
(
6
)
Alan Brochstein
(
6
)
Value Expectations
(
2
)
A. Reza Saadat
(
1
)
Most followed on SGEN
Don Dion
(
2198
)
Bespoke Investment Group
(
2135
)
Mike Havrilla
(
1086
)
Market Folly
(
1077
)
Andrew Mickey
(
833
)
Most commented on SGEN
Andrew Mickey
(
45
)
Ohad Hammer
(
38
)
Alan Brochstein
(
15
)
Value Expectations
(
12
)
Bespoke Investment Group
(
2
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Seattle Genetics, Inc. (SGEN)
by
latest
|
most commented
Top Biotech Picks for ASCO 2009 (Part II)
May 27
•
Ohad Hammer
•
CRGN
,
ARQL
,
EXEL
•
2 Comments
|
Quick Read
Top Biotech Picks for ASCO 2009 (Part I)
May 27
•
Ohad Hammer
•
CRGN
,
ARQL
,
EXEL
•
2 Comments
|
Quick Read
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
May 18
•
Mike Havrilla
•
CRGN
,
AMGN
,
ALTH
•
1 Comment
|
Quick Read
Where the Big Money Is Betting Big
May 15
•
Andrew Mickey
•
ALTH
,
AUY
,
AEM
•
45 Comments
|
Quick Read
20 Stocks Which May Be Threatening Your Portfolio
May 4
•
Value Expectations
•
BCL
,
ASYT
,
ACAD
•
9 Comments
|
Quick Read
20 Stocks to Avoid from Russell 2000
May 4
•
Value Expectations
•
BLC
,
ASYT
,
ACAD
•
3 Comments
|
Quick Read
Bright Prospects for Micromet (Part 2)
Apr 24
•
Ohad Hammer
•
IMGN
,
MEDX
,
MITI
•
3 Comments
|
Quick Read
Spicing Up the Biotech Portfolio with Microcaps CuraGen and Curis
Feb 23
•
Ohad Hammer
•
CRGN
,
CRXL
,
CRIS
•
Comment!
|
Quick Read
Rigel and Seattle Genetics: The Delicate Art of Expectation Management
Feb 9
•
Ohad Hammer
•
SGEN
,
RIGL
•
5 Comments
|
Quick Read
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
Jan 6
•
Market Folly
•
ABT
,
ABI
,
AAPL
•
2 Comments
|
Quick Read
'When There's Blood in the Streets', Buy Biotech Stocks
Oct 10, 2008
•
Ohad Hammer
•
AMGN
,
ALTH
,
ALNY
•
13 Comments
|
Quick Read
My Model Biotech Picks: What's Hot and What's Not
Aug 13, 2008
•
A. Reza Saadat
•
AMGN
,
ALNY
,
AMLN
•
Comment!
|
Quick Read
Genentech’s New ADC Platform Has Much Potential, but Is Yet to Be Tested on Humans
Aug 6, 2008
•
Ohad Hammer
•
IMGN
,
DNA
,
SGEN
•
2 Comments
|
Quick Read
Immunogen's Wild Swings Due to Lack of Information at ASCO
Jul 14, 2008
•
Ohad Hammer
•
IMGN
,
DNA
,
SGEN
•
3 Comments
|
Quick Read
ASCO: Whose Presentations Look the Most Promising?
May 27, 2008
•
Dan Rosenblum
•
IMCL
,
ARIA
,
CELG
•
1 Comment
|
Quick Read
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
May 9, 2008
•
Don Dion
•
CVTX
,
ALXN
,
ABI
•
1 Comment
|
Quick Read
Bill and Melinda Gates Foundation Holdings Outperforming S&P 500 Handily
Feb 26, 2008
•
Bespoke Investment Group
•
CMCSK
,
BRK.B
,
CLH
•
2 Comments
|
Quick Read
Micromet: Biting Cancer
Feb 6, 2008
•
Ohad Hammer
•
IMGN
,
MITI
,
SGEN
•
1 Comment
|
Quick Read
Seattle Genetics at ASH 2007 (Part III)
Dec 26, 2007
•
Ohad Hammer
•
SGEN
•
Comment!
|
Quick Read
Seattle Genetics at ASH 2007 (Part II)
Dec 23, 2007
•
Ohad Hammer
•
SGEN
•
Comment!
|
Quick Read
Seattle Genetics at ASH 2007 (Part I)
Dec 20, 2007
•
Ohad Hammer
•
SGEN
•
2 Comments
|
Quick Read
Seattle Genetics' Bright Future - Part II
Dec 6, 2007
•
Ohad Hammer
•
SGEN
•
Comment!
|
Quick Read
Seattle Genetics' Bright Future - Part I
Nov 21, 2007
•
Ohad Hammer
•
SGEN
•
2 Comments
|
Quick Read
Cancer Stocks Finish a Tough Quarter
Oct 1, 2007
•
Alan Brochstein
•
BIIB
,
ANX
,
CELG
•
Comment!
|
Quick Read
The "Naked" Truth About Antibodies For Cancer Therapy
Jul 5, 2007
•
Ohad Hammer
•
DNA
,
AMGN
,
IMCL
•
3 Comments
|
Quick Read
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
AFFY
,
AGEN
,
ABPI
•
7 Comments
|
Quick Read
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Biotech Day In Review: Regeneron Up On AMD Data
Mar 28, 2007
•
AGIX
,
ARXT
,
BCRX
•
Comment!
|
Quick Read
Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis
Feb 14, 2007
•
Centient Biotech Investor
•
BEC
,
CRTX
,
GSK
•
Comment!
|
Quick Read
Biotech Week In Review: Biotech Treks Higher
Feb 5, 2007
•
Centient Biotech Investor
•
AMGN
,
ARAY
,
BAX
•
Comment!
|
Quick Read
A Good Start for Biotech, Two Weeks in a Row
Jan 17, 2007
•
Centient Biotech Investor
•
DNA
,
GHDX
,
CYTR
•
1 Comment
|
Quick Read
Biotech Stocks Review: Amphora Sells Oncology Program to Genentech
Jan 10, 2007
•
Centient Biotech Investor
•
BIIB
,
AGIX
,
ALNY
•
Comment!
|
Quick Read
Biotech Stocks Review: Seattle Genetics Sells Cancer Drug To Genentech
Jan 9, 2007
•
Centient Biotech Investor
•
ALKS
,
CEPH
,
AZN
•
Comment!
|
Quick Read
Biotech Indices Mixed as AMEX Gains, Nasdaq Slips
Jan 9, 2007
•
H.S. Ayoub
•
BIOV
,
SGEN
,
BCRX
•
Comment!
|
Quick Read
Biotech Stocks Day-in-Review: Genentech Buys Altus' Pipeline
Dec 21, 2006
•
Centient Biotech Investor
•
CYTK
,
ARTE
,
CGPI
•
Comment!
|
Quick Read